Directory of funded grants

Filter by

721 results found

PET imaging of Alzheimer’s-induced inflammation to monitor progression and therapy response using a novel fructose-based radiotracer

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $99,986

  • Health Canada Contribution

    $49,993

Project Overview

Alzheimer's Disease (AD) is tough to diagnose as it requires understanding patient history, symptoms, blood tests,and brain scans. Current brain scans mainly look at how glucose and amyloid (a protein) behave, but these tests aren't very reliable. Researchers aim to create a new brain scan that can better identify AD…

Deep histological and pathological phenotyping of sporadic dementia

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    British Columbia

  • Start Date

    2025

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $100,000

Project Overview

Patients with dementia may have pure Alzheimer Disease (AD) pathology or a combination of pathologies called mixed dementia. In general, patients with younger age of onset (less than 65 years) tend to exhibit pure AD pathology, whereas older individuals are more likely to develop mixed dementia. Among the most common…

Signatures of early life stress as a risk factor for Alzheimer’s disease

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    Alberta

  • Start Date

    2025

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $100,000

Project Overview

Childhood stress increases the risk of Alzheimer’s Disease (AD). Early signs of AD appear in a part of the brain that produces serotonin, a chemical important for mood and memory-both of which are affected in AD. Serotonin is also sensitive to childhood trauma. Although there is a connection between early…

Ensuring equitable access to inpatient rehabilitation for people living with dementia: An effectiveness-implementation randomized trial

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $100,000

Project Overview

One in five older adults with dementia is hospitalized each year. One in three hospitalized older adults will lose independence in transferring, eating, ambulating, dressing, or bathing, which increases nursing home admission risk; this risk is 36% greater in people living with dementia (PLWD). Rehabilitation could decrease this risk, but…

A Pilot Randomized Trial of a Digital App, WhatMatters to enable Person-Centred Care

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    British Columbia

  • Start Date

    2025

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $100,000

Project Overview

Person-centred care is critical in supporting people with dementia, particularly in hospital settings where unmet needs can lead to responsive behaviors such as confusion and agitation. These behaviours are often caused by stress and are preventable through personalized, non-pharmacological interventions. WhatMatters is a digital app designed to support person-centred care…